PDCD1 and B-cell chronic lymphocytic leukemia: The expression of PD-L1, the ligand of PD-1, and of the inhibitory molecules CD200, CD276 and CD270, is enhanced in CLL cells, and their upregulation is causal for significant impairment in IS formation [157].